I pull together these thoughts for the Friday File throughout the week, and sometimes that means I end up feeling almost bipolar — the market sentiment on Monday was so wildly different than the sentiment this morning that our emotions can get a little whipsawed. Which means, of course, that I should be tuning down […]
Articles
Dr. David Eifrig has usually one of the more sober pitchmen at Stansberry (odd choice of words for a guy who owns a winery, I guess), and his Retirement Millionaire newsletter (usually sold at $49/yr, renews at $199) is probably his most conservative product — offering up “retirement living” lifestyle advice as well as what […]
Options trading course.
Quite a few eagle-eyed Gumshoe readers forwarded the latest ad from Dr. David Eifrig to us over the weekend — he’s pitching his Retirement Millionaire newsletter, which is an “entry level” offering from Stansberry that includes money-saving retirement tips and health tips as well as investment ideas. It tends to not be an aggressive or […]
This week a pitch from Matt Badiali got me to thinking — it came in as a free article with a little “cross-selling” pitch from another Stansberry publication, Retirement Millionaire, and it sounded a little bit familiar… so I thought we’d start with that today and see where it takes us. The intro from David […]
The latest ad from Dr. David Eifrig for his Income Intelligence service (published by Stansberry) makes it seem like there’s something secretive and amazing happening that will boost your portfolio… and it’s happening immediately and on a specific date (September 16). So what is it? Here’s the intro to the ad: “Last year, two of […]
The following was originally published on November 10 and has not been updated or revised. The teaser ad covered is being circulated again today with a slightly different headline pitch about cellphone royalties, but the balance of the ad (and the teased company) are largely unchanged. —from 11/10/14— Dr. David Eifrig is touting something that […]
Immunotherapy for cancer has been in the news quite a bit in recent years, with several drugs making an impact on the worst cancers and giving some real hope for future advancement — not a small thing for a basic medical strategy that’s been tested and tweaked for 125 years now by folks following in […]
It’s like the Stansberry folks know what appeals to your friendly neighborhood Stock Gumshoe… and they just can’t get enough of our coverage. Every time I turn around lately they’re teasing and promoting a different kind of “royalty” company. And I loves me some royalties. Royalty companies are pretty well understood by most investors — […]
We’re rerunning this piece because it continues to be one of the most asked-for explanations on the Stock Gumshoe website. What follows below was originally published in mid-2012, it has been updated for the change in silver values but otherwise remains unchanged. Dr. David Eifrig over at Stansberry’s Retirement Millionaire newsletter has been teasing us […]
Well, and we also love you — of course. Just wanted to make sure you know that on this lovely Valentine’s Day. We are inundated every day with email ads that our loyal readers forward on to us, and we appreciate every one — we want to know who’s promising you 1,000% returns, or who’s […]
Before I get on to that “laziest minority” bit, I did want to throw out a few comments and some thoughts about a few stocks I follow closely: If you don’t think the world is going to hell in a handbasket, and you do think that commodities in general will hold up reasonably well (which […]
Active trading newsletter, tends to focus on income and options trades.
Never does this get boring. Every time thing seem to run a little dry here at Gumshoe HQ, and the reservoir of hypetastic teasers dips a little bit below the intake pipe … well, the flood comes again, regular as the rains (if not quite as seasonal). That’s how it’s been for a thousand teaser […]
How can you find sacks of treasure located around 776 cities around the country? That’s the pitch from Retirement Millionaire from Stansberry & Associates — the ad, which is one of those good ol’ video ads that doesn’t happen to link to a text version, even includes a “treasure map” of those cities around the […]
If you’ve been treading the boards at the good ol’ Gumshoe Theater of Oddities for more than a few months, this teaser for silver may sound familiar to you: “How To Buy U.S. Government Created Silver For $2.08” The tease is an attempt to get you to sign up for Dr. David Eifrig’s Retirement Millionaire […]
Dr. David Eifrig is one of the Stansberry writer/editors, and for a couple of years now he has put out the Retirement Millionaire newsletter that seems to be largely focused on ways to get special perqs and discounts as a retireee … as well as a bit of financial commentary and ideas, I’m told (I […]
Dr. David Eifrig, who I’ve written about once or twice before, has stepped away from his usual Retirement Millionaire topics to write about an individual stock — well, tease us about a stock, anyway. If you’ll sign up for the good doctor’s newsletter to find out about his favorite retirement freebies and savings strategies, he’ll […]
Coverage of retirement issues, discounts and deals, and investment strategies and concepts. Not focused solely on being an investment-picking letter but does make recommendations.
This ad sounds a little bit like a very popular one we looked at a few months back — then, it was for $1 “Silver Shots”, and it was a teaser for a leveraged derivative trade on silver futures (or, in plainer speak, it was for long-term call options on the SLV ETF). If you […]
Monthly newsletter that focuses on high-dividend stocks and similar investments. (Formerly edited by Tom Dyson, who left to found the Palm Beach Letter publications with Mark Ford) This letter was merged into Stansberry’s Income Intelligence letter, edited by Dr. David Eifrig.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Dr. Eifrig's name translated from German as "eager", so how is that relevant here? Where does that lead us?...
I once asked Dr.David Eifrig why not buy deep out of the money Silver call options (Leaps even) for a potential Silver p...